{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:05:31Z","timestamp":1791317131891,"version":"4.3.1"},"reference-count":92,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":688,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"crossref"}]},{"name":"4TEEN4 Pharmaceuticals GmbH"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Intensive Care"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1186\/s13613-024-01325-y","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T18:01:34Z","timestamp":1718388094000},"page":"89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Impaired angiotensin II signaling in septic shock"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0639-5598","authenticated-orcid":false,"given":"Adrien","family":"Picod","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Van Lier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Pickkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Herpain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Mebazaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feriel","family":"Azibani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1186\/s13613-024-01325-y_bb0010","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"18","key":"10.1186\/s13613-024-01325-y_bb0015","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJMra1208943","article-title":"Circulatory shock","volume":"369","author":"Vincent","year":"2013","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1186\/s13613-024-01325-y_bb0020","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"issue":"5","key":"10.1186\/s13613-024-01325-y_bb0025","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1186\/s13613-024-01325-y_bb0030","first-page":"1","article-title":"Regulation of renin release by local and systemic factors","volume":"161","author":"Schweda","year":"2011","journal-title":"Rev Physiol Biochem Pharmacol"},{"issue":"3","key":"10.1186\/s13613-024-01325-y_bb0035","first-page":"465","article-title":"Mechanisms for inducible control of angiotensinogen gene transcription","volume":"27","author":"Brasier","year":"1996","journal-title":"Hypertens Dallas Tex 1979."},{"issue":"1","key":"10.1186\/s13613-024-01325-y_bb0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0002-9343(91)90501-N","article-title":"Low angiotensinogen levels are related to the severity and liver dysfunction of congestive heart failure: implications for renin measurements","volume":"90","author":"Arnal","year":"1991","journal-title":"Am J Med"},{"issue":"1","key":"10.1186\/s13613-024-01325-y_bb0045","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0167-4838(87)90226-3","article-title":"Comparative enzymatic studies of human renin acting on pure natural or synthetic substrates","volume":"913","author":"Cumin","year":"1987","journal-title":"Biochim Biophys Acta"},{"issue":"5117","key":"10.1186\/s13613-024-01325-y_bb0050","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/216762a0","article-title":"Conversion of angiotensin I to angiotensin II","volume":"216","author":"Ng","year":"1967","journal-title":"Nature"},{"issue":"3","key":"10.1186\/s13613-024-01325-y_bb0055","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","article-title":"Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology","volume":"98","author":"Forrester","year":"2018","journal-title":"Physiol Rev"},{"issue":"20","key":"10.1186\/s13613-024-01325-y_bb0060","doi-asserted-by":"crossref","first-page":"12043","DOI":"10.1016\/S0021-9258(18)33674-3","article-title":"Dipeptidyl-aminopeptidase III of rat brain. Selective affinity for enkephalin and angiotensin","volume":"257","author":"Lee","year":"1982","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1186\/s13613-024-01325-y_bb0065","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1748-1716.2006.01595.x","article-title":"Systemic effects of angiotensin III in conscious dogs during acute double blockade of the renin-angiotensin-aldosterone-system","volume":"188","author":"Gammelgaard","year":"2006","journal-title":"Acta Physiol Oxf Engl"},{"issue":"52","key":"10.1186\/s13613-024-01325-y_bb0070","doi-asserted-by":"crossref","first-page":"48623","DOI":"10.1074\/jbc.C100512200","article-title":"Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase","volume":"276","author":"Albiston","year":"2001","journal-title":"J Biol Chem"},{"issue":"26","key":"10.1186\/s13613-024-01325-y_bb0075","doi-asserted-by":"crossref","first-page":"23107","DOI":"10.1074\/jbc.C200201200","article-title":"Angiotensin IV is a potent agonist for constitutive active human AT1 receptors. Distinct roles of the N-and C-terminal residues of angiotensin II during AT1 receptor activation","volume":"277","author":"Le","year":"2002","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1186\/s13613-024-01325-y_bb0080","first-page":"1138","article-title":"Angiotensin-(1\u20137)","volume":"63","author":"Santos","year":"2014","journal-title":"Hypertens Dallas Tex 1979."},{"issue":"2","key":"10.1186\/s13613-024-01325-y_bb0085","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/01.ATV.0000253889.09765.5f","article-title":"Mass-spectrometric identification of a novel angiotensin peptide in human plasma","volume":"27","author":"Jankowski","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"10.1186\/s13613-024-01325-y_bb0090","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCRESAHA.113.301077","article-title":"Discovery and characterization of alamandine: a novel component of the renin-angiotensin system","volume":"112","author":"Lautner","year":"2013","journal-title":"Circ Res"},{"issue":"5","key":"10.1186\/s13613-024-01325-y_bb0095","doi-asserted-by":"crossref","first-page":"H958","DOI":"10.1152\/ajpheart.00723.2018","article-title":"The renin-angiotensin system: going beyond the classical paradigms","volume":"316","author":"Santos","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"10.1186\/s13613-024-01325-y_bb0100","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1161\/01.CIR.83.4.1333","article-title":"Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II","volume":"83","author":"Christen","year":"1991","journal-title":"Circulation"},{"issue":"1","key":"10.1186\/s13613-024-01325-y_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.CIR.85.1.1","article-title":"Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition","volume":"85","author":"Kiowski","year":"1992","journal-title":"Circulation"},{"issue":"3","key":"10.1186\/s13613-024-01325-y_bb0110","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/ki.1977.28","article-title":"Angiotensin II blockade in normal man: interaction of renin and sodium in maintaining blood pressure","volume":"11","author":"Posternak","year":"1977","journal-title":"Kidney Int"},{"issue":"1","key":"10.1186\/s13613-024-01325-y_bb0115","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/ALN.0000000000001404","article-title":"Withholding versus Continuing Angiotensin-converting Enzyme Inhibitors or Angiotensin II Receptor Blockers before Noncardiac Surgery: An Analysis of the Vascular events In noncardiac Surgery patIents cOhort evaluatioN Prospective Cohort","volume":"126","author":"Roshanov","year":"2017","journal-title":"Anesthesiology"},{"issue":"5","key":"10.1186\/s13613-024-01325-y_bb0120","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/00000542-199405000-00008","article-title":"Endogenous vasopressin and renin-angiotensin systems support blood pressure after epidural block in humans","volume":"80","author":"Carp","year":"1994","journal-title":"Anesthesiology"},{"issue":"5","key":"10.1186\/s13613-024-01325-y_bb0125","first-page":"S121","article-title":"The interaction between noradrenaline and angiotensin II in man: evidence for a postsynaptic and against a presynaptic interaction","volume":"5","author":"Seidelin","year":"1987","journal-title":"J Hypertens Suppl Off J Int Soc Hypertens"},{"issue":"11","key":"10.1186\/s13613-024-01325-y_bb0130","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1097\/01.CCM.0000186759.13325.DC","article-title":"Marked synergism between vasopressin and angiotensin II in a human isolated artery","volume":"33","author":"Hidaka","year":"2005","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1186\/s13613-024-01325-y_bb0135","first-page":"R190","article-title":"Control of glomerular filtration rate by circulating angiotensin II","volume":"241","author":"Hall","year":"1981","journal-title":"Am J Physiol"},{"issue":"1","key":"10.1186\/s13613-024-01325-y_bb0140","first-page":"S23","article-title":"Clinical pharmacology of the angiotensin II receptor antagonist losartan potassium in healthy subjects","volume":"13","author":"Burnier","year":"1995","journal-title":"J Hypertens Suppl Off J Int Soc Hypertens"},{"issue":"1","key":"10.1186\/s13613-024-01325-y_bb0145","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/14703203010020013501","article-title":"Angiotensin II blockade causes acute renal failure in eNOS-deficient mice","volume":"2","author":"Schnermann","year":"2001","journal-title":"J Renin-Angioten-Aldostere Syst JRAAS"},{"issue":"8","key":"10.1186\/s13613-024-01325-y_bb0150","doi-asserted-by":"crossref","first-page":"e550","DOI":"10.1097\/CCM.0000000000000397","article-title":"Angiotensin II in septic shock: effects on tissue perfusion, organ function, and mitochondrial respiration in a porcine model of fecal peritonitis","volume":"42","author":"Corr\u00eaa","year":"2014","journal-title":"Crit Care Med"},{"key":"10.1186\/s13613-024-01325-y_bb0155","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.kint.2020.07.047","article-title":"Impaired angiotensin II type 1 receptor signaling contributes to sepsis induced acute kidney injury","volume":"99","author":"Leisman","year":"2020","journal-title":"Kidney Int"},{"issue":"9","key":"10.1186\/s13613-024-01325-y_bb0160","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1007\/s00134-007-0734-8","article-title":"Renal blood flow and function during recovery from experimental septic acute kidney injury","volume":"33","author":"Langenberg","year":"2007","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1186\/s13613-024-01325-y_bb0165","doi-asserted-by":"crossref","first-page":"R190","DOI":"10.1186\/cc8185","article-title":"Angiotensin II in experimental hyperdynamic sepsis","volume":"13","author":"Wan","year":"2009","journal-title":"Crit Care Lond Engl"},{"issue":"2","key":"10.1186\/s13613-024-01325-y_bb0170","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/ar.1092010204","article-title":"Shunting in renal microvasculature of the rat: a scanning electron microscopic study of corrosion casts","volume":"201","author":"Casellas","year":"1981","journal-title":"Anat Rec"},{"issue":"1","key":"10.1186\/s13613-024-01325-y_bb0175","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1097\/CCM.0b013e3182a639da","article-title":"Renal histopathology during experimental septic acute kidney injury and recovery","volume":"42","author":"Langenberg","year":"2014","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1186\/s13613-024-01325-y_bb0180","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/CCM.0000000000003544","article-title":"Renin as a marker of tissue-perfusion and prognosis in critically Ill patients","volume":"47","author":"Gleeson","year":"2019","journal-title":"Crit Care Med"},{"key":"10.1186\/s13613-024-01325-y_bb0185","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1164\/rccm.201911-2172OC","article-title":"Renin and survival in patients given angiotensin II for catecholamine-resistant vasodilatory shock","volume":"202","author":"Bellomo","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1186\/s13613-024-01325-y_bb0190","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s13054-021-03725-z","article-title":"Serum renin and major adverse kidney events in critically ill patients: a multicenter prospective study","volume":"25","author":"Flannery","year":"2021","journal-title":"Crit Care Lond Engl"},{"key":"10.1186\/s13613-024-01325-y_bb0195","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/CCM.0000000000006095","article-title":"Association of active renin content with mortality in critically Ill patients: a post hoc analysis of the vitamin C, thiamine, and steroids in sepsis trial","volume":"52","author":"Busse","year":"2023","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1186\/s13613-024-01325-y_bb0200","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13054-020-2733-x","article-title":"Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock","volume":"24","author":"Bellomo","year":"2020","journal-title":"Crit Care Lond Engl."},{"issue":"4","key":"10.1186\/s13613-024-01325-y_bb0205","first-page":"439","article-title":"Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides","volume":"23","author":"Campbell","year":"1994","journal-title":"Hypertens Dallas Tex 1979."},{"issue":"9","key":"10.1186\/s13613-024-01325-y_bb0210","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/00003246-198109000-00008","article-title":"Decreased serum angiotensin converting enzyme in adult respiratory distress syndrome associated with sepsis: a preliminary report","volume":"9","author":"Casey","year":"1981","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1186\/s13613-024-01325-y_bb0215","first-page":"257","article-title":"VE-cadherin and ACE: markers for sepsis in post mortem examination?","volume":"10","author":"M\u00fcller","year":"2008","journal-title":"Leg Med Tokyo Jpn"},{"issue":"Suppl 1","key":"10.1186\/s13613-024-01325-y_bb0220","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40121-018-0192-3","article-title":"Activated protein C has no effect on pulmonary capillary endothelial function in septic patients with acute respiratory distress syndrome: association of endothelial dysfunction with mortality","volume":"7","author":"Kaziani","year":"2018","journal-title":"Infect Dis Ther"},{"issue":"10","key":"10.1186\/s13613-024-01325-y_bb0225","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1164\/rccm.201912-2504LE","article-title":"Equilibrium angiotensin metabolite profiling in patients with acute respiratory distress syndrome indicates angiotensin-converting enzyme inhibition","volume":"202","author":"Krenn","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1186\/s13613-024-01325-y_bb0230","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s13054-023-04518-2","article-title":"Genomics of Pediatric Septic Shock Investigators. Increasing angiotensin-converting enzyme concentrations and absent angiotensin-converting enzyme activity are associated with adverse kidney outcomes in pediatric septic shock","volume":"27","author":"Pode-Shakked","year":"2023","journal-title":"Crit Care Lond Engl."},{"issue":"1","key":"10.1186\/s13613-024-01325-y_bb0235","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1152\/ajplegacy.1969.216.1.5","article-title":"Inactivation of angiotensin in shock","volume":"216","author":"Itskovitz","year":"1969","journal-title":"Am J Physiol"},{"issue":"6","key":"10.1186\/s13613-024-01325-y_bb0240","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1373\/jalm.2018.027995","article-title":"Novel methods for the quantification of dipeptidyl peptidase 3 (DPP3) concentration and activity in human blood samples","volume":"3","author":"Rehfeld","year":"2019","journal-title":"J Appl Lab Med"},{"issue":"8","key":"10.1186\/s13613-024-01325-y_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238039","article-title":"Inhibition of circulating dipeptidyl-peptidase 3 restores cardiac function in a sepsis-induced model in rats: a proof of concept study","volume":"15","author":"Deniau","year":"2020","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1186\/s13613-024-01325-y_bb0250","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1164\/rccm.202010-3873LE","article-title":"Alteration of the renin-angiotensin-aldosterone system in shock: role of the dipeptidyl peptidase 3","volume":"203","author":"Picod","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1186\/s13613-024-01325-y_bb0255","first-page":"927","article-title":"Circulating dipeptidyl peptidase 3 modulates systemic and renal hemodynamics through cleavage of angiotensin peptides","volume":"81","author":"Picod","year":"2024","journal-title":"Hypertens Dallas Tex 1979."},{"issue":"1","key":"10.1186\/s13613-024-01325-y_bb0260","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13054-021-03471-2","article-title":"Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational study","volume":"25","author":"Blet","year":"2021","journal-title":"Crit Care Lond Engl"},{"issue":"2","key":"10.1186\/s13613-024-01325-y_bb0265","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1016\/j.bja.2021.11.021","article-title":"High plasma dipeptidyl peptidase 3 levels are associated with mortality and organ failure in shock: results from the international, prospective and observational FROG-ICU cohort","volume":"128","author":"Deniau","year":"2022","journal-title":"Br J Anaesth"},{"issue":"Pt 1","key":"10.1186\/s13613-024-01325-y_bb0270","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1042\/BJ20040634","article-title":"Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism","volume":"383","author":"Rice","year":"2004","journal-title":"Biochem J"},{"issue":"4","key":"10.1186\/s13613-024-01325-y_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231555","article-title":"Dysregulated activities of proline-specific enzymes in septic shock patients (sepsis-2)","volume":"15","author":"Vliegen","year":"2020","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1186\/s13613-024-01325-y_bb0280","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/ehf2.13787","article-title":"Soluble neprilysin and survival in critically ill patients","volume":"9","author":"Lenz","year":"2022","journal-title":"ESC Heart Fail"},{"issue":"9","key":"10.1186\/s13613-024-01325-y_bb0285","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1097\/CCM.0b013e318183f067","article-title":"Impaired plasma B-type natriuretic peptide clearance in human septic shock","volume":"36","author":"Pirracchio","year":"2008","journal-title":"Crit Care Med"},{"issue":"8","key":"10.1186\/s13613-024-01325-y_bb0290","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jchf.2015.03.011","article-title":"Elevated plasma B-type natriuretic peptide concentrations directly inhibit circulating neprilysin activity in heart failure","volume":"3","author":"Vodovar","year":"2015","journal-title":"JACC Heart Fail"},{"issue":"12","key":"10.1186\/s13613-024-01325-y_bb0295","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1091\/mbc.e03-06-0383","article-title":"The angiotensin II type I receptor-associated protein, ATRAP, is a transmembrane protein and a modulator of angiotensin II signaling","volume":"14","author":"Lopez-Ilasaca","year":"2003","journal-title":"Mol Biol Cell"},{"issue":"4","key":"10.1186\/s13613-024-01325-y_bb0300","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.bbrc.2003.09.154","article-title":"Type 1 angiotensin II receptor-associated protein ARAP1 binds and recycles the receptor to the plasma membrane","volume":"310","author":"Guo","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"10.1186\/s13613-024-01325-y_bb0305","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1097\/CCM.0b013e318218665a","article-title":"Association of angiotensin II type 1 receptor-associated protein gene polymorphism with increased mortality in septic shock","volume":"39","author":"Nakada","year":"2011","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1186\/s13613-024-01325-y_bb0310","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1186\/cc12809","article-title":"The angiotensin II AT1 receptor-associated protein Arap1 is involved in sepsis-induced hypotension","volume":"17","author":"Mederle","year":"2013","journal-title":"Crit Care Lond Engl"},{"issue":"2","key":"10.1186\/s13613-024-01325-y_bb0315","first-page":"177","article-title":"Downregulation of angiotensin II type 1 receptors during sepsis","volume":"38","author":"Bucher","year":"2001","journal-title":"Hypertens Dallas Tex 1979."},{"issue":"1","key":"10.1186\/s13613-024-01325-y_bb0320","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cyto.2009.10.006","article-title":"Blockade of multiple but not single cytokines abrogates downregulation of angiotensin II type-I receptors and anticipates septic shock","volume":"49","author":"Schmidt","year":"2010","journal-title":"Cytokine"},{"issue":"9","key":"10.1186\/s13613-024-01325-y_bb0325","doi-asserted-by":"crossref","first-page":"e945","DOI":"10.1097\/CCM.0000000000003296","article-title":"MicroRNA-155 amplifies nitric oxide\/cGMP signaling and impairs vascular angiotensin II reactivity in septic shock","volume":"46","author":"Vasques-N\u00f3voa","year":"2018","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1186\/s13613-024-01325-y_bb0330","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13054-024-04910-6","article-title":"ACE inhibitors and angiotensin receptor blockers differentially alter the response to angiotensin II treatment in vasodilatory shock","volume":"28","author":"Leisman","year":"2024","journal-title":"Crit Care Lond Engl"},{"issue":"4","key":"10.1186\/s13613-024-01325-y_bb0335","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1210\/jcem-53-4-867","article-title":"Hyperreninemic hypoaldosteronism in the critically ill: a new entity","volume":"53","author":"Zipser","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1186\/s13613-024-01325-y_bb0340","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1210\/jcem-64-3-592","article-title":"The dissociation of renin and aldosterone during critical illness","volume":"64","author":"Findling","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1186\/s13613-024-01325-y_bb0345","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s00134-003-1986-6","article-title":"Hyperreninemic hypoaldosteronism: a possible etiological factor of septic shock-induced acute renal failure","volume":"29","author":"du Cheyron","year":"2003","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1186\/s13613-024-01325-y_bb0350","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s13054-022-04161-3","article-title":"Myocardial effects of angiotensin II compared to norepinephrine in an animal model of septic shock","volume":"26","author":"Garcia","year":"2022","journal-title":"Crit Care Lond Engl"},{"issue":"178","key":"10.1186\/s13613-024-01325-y_bb0355","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/jama.1961.03040490020005","article-title":"Clinical experience with angiotensin II in the treatment of shock","volume":"9","author":"Del Greco","year":"1961","journal-title":"JAMA"},{"key":"10.1186\/s13613-024-01325-y_bb0360","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1161\/01.CIR.25.1.263","article-title":"Adjunctive use of a biologic pressor agent, angiotensin, in management of shock","volume":"25","author":"Derrick","year":"1962","journal-title":"Circulation"},{"issue":"6","key":"10.1186\/s13613-024-01325-y_bb0365","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/CCM.0000000000003092","article-title":"Outcomes in patients with vasodilatory shock and renal replacement therapy treated with intravenous angiotensin II","volume":"46","author":"Tumlin","year":"2018","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1186\/s13613-024-01325-y_bb0370","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13613-023-01227-5","article-title":"Angiotensin II treatment is associated with improved oxygenation in ARDS patients with refractory vasodilatory shock","volume":"13","author":"Leisman","year":"2023","journal-title":"Ann Intensive Care"},{"issue":"5","key":"10.1186\/s13613-024-01325-y_bb0375","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s13054-014-0534-9","article-title":"Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study","volume":"18","author":"Chawla","year":"2014","journal-title":"Crit Care Lond Engl"},{"issue":"1","key":"10.1186\/s13613-024-01325-y_bb0380","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13054-016-1306-5","article-title":"The use of angiotensin II in distributive shock","volume":"20","author":"Chawla","year":"2016","journal-title":"Crit Care Lond Engl"},{"issue":"1","key":"10.1186\/s13613-024-01325-y_bb0385","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13613-019-0536-5","article-title":"Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial","volume":"9","author":"Ham","year":"2019","journal-title":"Ann Intensive Care"},{"issue":"9","key":"10.1186\/s13613-024-01325-y_bb0390","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1164\/rccm.202005-2050OC","article-title":"Kinetic changes of plasma renin concentrations predict acute kidney injury in cardiac surgery patients","volume":"203","author":"K\u00fcllmar","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1186\/s13613-024-01325-y_bb0395","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13054-019-2420-y","article-title":"Broad spectrum vasopressors: a new approach to the initial management of septic shock?","volume":"23","author":"Chawla","year":"2019","journal-title":"Crit Care Lond Engl"},{"issue":"11","key":"10.1186\/s13613-024-01325-y_bb0400","first-page":"685","article-title":"Angiotensin II brings more questions than answers","volume":"43","author":"Farina","year":"2018","journal-title":"P T Peer-Rev J Formul Manag"},{"key":"10.1186\/s13613-024-01325-y_bb0405","unstructured":"La Jolla Pharmaceutical Company. GIAPREZA (angiotensin II) package insert. 2018;"},{"issue":"9","key":"10.1186\/s13613-024-01325-y_bb0410","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1164\/rccm.202012-4419ED","article-title":"The Yin and Yang of the Renin-Angiotensin-Aldosterone System in Acute Kidney Injury","volume":"203","author":"Legrand","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1186\/s13613-024-01325-y_bb0415","doi-asserted-by":"crossref","first-page":"H137","DOI":"10.1152\/ajpheart.00618.2015","article-title":"Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?","volume":"310","author":"Chappell","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"10.1186\/s13613-024-01325-y_bb0420","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/clinchem\/38.4.598","article-title":"Specimen processing and renin activity in plasma","volume":"38","author":"Nicar","year":"1992","journal-title":"Clin Chem"},{"issue":"3","key":"10.1186\/s13613-024-01325-y_bb0425","first-page":"e29","article-title":"Concerns on the specificity of commercial ELISAs for the measurement of angiotensin (1\u20137) and Angiotensin II in human plasma","volume":"77","author":"Chappell","year":"2021","journal-title":"Hypertens Dallas Tex 1979."},{"issue":"5","key":"10.1186\/s13613-024-01325-y_bb0430","doi-asserted-by":"crossref","first-page":"F487","DOI":"10.1152\/ajprenal.00206.2014","article-title":"A functional (pro)renin receptor is expressed in human lymphocytes and monocytes","volume":"308","author":"Narumi","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"issue":"9","key":"10.1186\/s13613-024-01325-y_bb0435","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1172\/JCI119000","article-title":"Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver","volume":"98","author":"V\u00e9niant","year":"1996","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1186\/s13613-024-01325-y_bb0440","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/sj.ki.5000011","article-title":"Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms","volume":"69","author":"Huang","year":"2006","journal-title":"Kidney Int"},{"issue":"34","key":"10.1186\/s13613-024-01325-y_bb0445","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2211370119","article-title":"Angiotensin II enhances bacterial clearance via myeloid signaling in a murine sepsis model","volume":"119","author":"Leisman","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"24","key":"10.1186\/s13613-024-01325-y_bb0450","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1161\/CIRCULATIONAHA.108.784868","article-title":"Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction?","volume":"118","author":"Kaschina","year":"2008","journal-title":"Circulation"},{"issue":"1 Pt 2","key":"10.1186\/s13613-024-01325-y_bb0455","first-page":"150","article-title":"Implications of species difference for clinical investigation: studies on the renin-angiotensin system","volume":"35","author":"Hollenberg","year":"2000","journal-title":"Hypertens Dallas Tex 1979."},{"issue":"1","key":"10.1186\/s13613-024-01325-y_bb0460","first-page":"59","article-title":"Angiotensin-converting enzyme (ACE) in sepsis","volume":"11","author":"Rice","year":"1983","journal-title":"Circ Shock"},{"issue":"3","key":"10.1186\/s13613-024-01325-y_bb0465","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.regpep.2003.12.013","article-title":"Relationship between contents of adrenomedullin and distributions of neutral endopeptidase in blood and tissues of rats in septic shock","volume":"118","author":"Jiang","year":"2004","journal-title":"Regul Pept"}],"container-title":["Annals of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-024-01325-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13613-024-01325-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025002419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025002419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-024-01325-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:37:34Z","timestamp":1776670654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2110582025002419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"alternative-id":["S2110582025002419"],"URL":"https:\/\/doi.org\/10.1186\/s13613-024-01325-y","relation":{},"ISSN":["2110-5820"],"issn-type":[{"value":"2110-5820","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impaired angiotensin II signaling in septic shock","name":"articletitle","label":"Article Title"},{"value":"Annals of Intensive Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/s13613-024-01325-y","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 The Author(s) 2024. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}],"article-number":"89"}}